Clinical trials: Grass Pollen Allergic Rhinitis

Rhinitis Allergic, Conjunctivitis

A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)

• Completed
• Age: 5 to 65 years
• Phase 3
• Results posted

This is a study to evaluate the efficacy and safety of grass sublingual tablet (SCH 697243) versus placebo in the treatment of grass pollen-induced allergic hayfever symptoms.

Trial name

NCT01385371

Testing

Grass (Phleum pratense) pollen allergen extract

Volunteers

1,501 people

Sponsor

ALK-Abelló A/S